Picture of Axonics logo

AXNX — Axonics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge Cap

Axonics Inc reports results for the quarter ended in September - Earnings Summary

* Axonics Inc  AXNX.OQ  reported a quarterly adjusted loss
of 34
cents​​ per share for the quarter ended in September. The mean
expectation of nine analysts for the quarter was for a loss
of 48 cents per share.
    * Revenue rose 50% to $70.38 million from a year ago;
analysts
expected $62.98 million. 
    * Axonics Inc's reported EPS for the quarter was a loss
of 34
cents​.
    * The mean earnings estimate of analysts had risen by
about 6.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Axonics Inc shares had risen by 2.1% this quarter and
gained 28.4% so far this year.
    * The company reported a quarterly loss of $28.31 million.
    * Wall Street's median 12-month price target for Axonics Inc
is
$84.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data October
31 at 09:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.48          -0.34          Beat
 Jun. 30 2022      -0.54          -0.47          Beat
 Mar. 31 2022      -0.63          -0.50          Beat
 Dec. 31 2021      -0.37          -0.34          Beat

Recent news on Axonics

See all news